Omega Fund Management’s Gossamer Bio GOSS Stock Holding History

Omega Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,750	Closed	-$18M	–	18
2022 Q3	$18M	Hold	18,750	–	–	6.58%	5
2022 Q2	$12.6M	Sell	18,750 -20,810	-53%	-$12.9M	4.01%	9
2022 Q1	$27.5M	Hold	39,560	–	–	5.62%	6
2021 Q4	$35.8M	Sell	39,560 -1,948	-5%	-$1.85M	5.06%	6
2021 Q3	$41.7M	Hold	41,508	–	–	4.68%	6
2021 Q2	$27M	Hold	41,508	–	–	3.05%	6
2021 Q1	$30.7M	Hold	41,508	–	–	2.91%	8
2020 Q4	$32.1M	Hold	41,508	–	–	4.82%	6
2020 Q3	$41.2M	Hold	41,508	–	–	11.15%	3
2020 Q2	$43.2M	Sell	41,508 -11,939	-22%	-$12M	11.8%	3
2020 Q1	$43.4M	Sell	53,447 -23,045	-30%	-$24.1M	17.96%	3
2019 Q4	$95.6M	Sell	76,492 -5,422	-7%	-$8.74M	30.44%	1
2019 Q3	$110M	Sell	81,914 -5,004	-6%	-$7.96M	33.96%	1
2019 Q2	$154M	Hold	86,918	–	–	39.34%	1
2019 Q1	$151M	Buy	+86,918	New	+$145M	48.31%	1

Other funds holding GOSS

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $9.5B AUM 55.06% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Omega Fund Management's GOSS Position: Q4 2022 in Review

Omega Fund Management sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 18,750 shares — an estimated $18M sold.

Omega Fund Management first reported a position in GOSS in Q1 2019 and held it in 15 quarters. The position peaked at $154M in Q2 2019. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

Omega Fund Management reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
Omega Fund Management sold 18,750 Gossamer Bio shares in Q4 2022, an estimated $18M.
Omega Fund Management first reported a position in Gossamer Bio in Q1 2019 and held it in 15 quarters.
Omega Fund Management's Gossamer Bio position peaked at $154M in Q2 2019.
118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Omega Fund Management's 13F filing for Q4 2022, filed 13 Feb 2023.